Condition: Small Cell Lung Cancer · Sponsor: Yunpeng Liu
To evaluate the efficacy and safety of maintenance therapy with Adebrelimab plus Apatinib for extensive stage small cell lung cancer after first-line induction of Adebrelimab plus chemotherapy.
This description comes directly from the study's public registry record.
Xiujuan Qu · 13604031355 · cmu1h_zlnk_trial@163.com
Always discuss trial participation with your own doctor first.
| The First Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| The First Hospital of China Medical University | Shenyang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06480864